Journal of psychopharmacology (Oxford, England)
The phytocannabinoid cannabidivarin alleviates cognitive and social behaviour deficits in the sub-chronic phencyclidine rat model of relevance for schizophrenia.
Ben Grayson, Giovanni Podda, Jackie Cilia, Marie Woolley-Roberts, Joanna C Neill, Jennifer Fletcher, Michael Harte
Published: 202510.1177/02698811251381246
Abstract
BACKGROUND: Schizophrenia is a serious psychiatric disorder that affects over 24 million people worldwide. Current therapies treat positive symptoms but show little efficacy for negative and cognitive symptoms, which can impact quality of life. Devel…
Preview only. Read the full abstract at the source